Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Frontiers in Cardiovascular Medicine|February 14, 2022
Concurrent Takayasu Arteritis and Vascular Ehlers-Danlos Syndrome: A Case ReportKyota Hashimoto, Ryota Sakai, Akiko Shibata, et al.
Immunological Medicine|January 31, 2025
Chronic kidney disease and inflammatory cytokines in rheumatoid arthritis: a potential pathogenic linkHironari Hanaoka, Takumi Aoki, Taiji Kosaka, et al.
Modern Rheumatology|March 3, 2016
Corticosteroid-free treatment of tocilizumab monotherapy for microscopic polyangiitis: a single-arm, single-center, clinical trialRyota Sakai, Tsuneo Kondo, Jun Kikuchi, et al.
Rheumatology (Oxford, England)|October 31, 2019
Tocilizumab monotherapy for large vessel vasculitis: results of 104-week treatment of a prospective, single-centre, open studyShuntaro Saito, Ayumi Okuyama, Yusuke Okada, et al.
Biochemical and Biophysical Research Communications|November 13, 2015
A novel JAK-STAT inhibitor, 2-[(3-Carbamoyl-2-thienyl)amino]-2-oxoethyl(2,6-dichlorophenyl)acetate, suppresses helper T cell differentiation in vitro and collagen-induced arthritis in vivoMayako Asakawa, Hideyuki Yoshida, Ryota Sakai, et al.
Yeast (Chichester, England)|April 23, 2013
Designed construction of recombinant DNA at the ura3Δ0 locus in the yeast Saccharomyces cerevisiaeTomoaki Fukunaga, Kamonchai Cha-Aim, Yuki Hirakawa, et al.
Frontiers in Medicine|October 18, 2021
Potential Triggers for Thrombocytopenia and/or Hemorrhage by the BNT162b2 Vaccine, Pfizer-BioNTechYusuke Okada, Ryota Sakai, Marie Sato-Fitoussi, et al.
Clinical & Translational Immunology|November 9, 2020
Tocilizumab monotherapy uncovered the role of the CCL22/17-CCR4+ Treg axis during remission of crescentic glomerulonephritisRyota Sakai, Minako Ito, Keiko Yoshimoto, et al.
Modern Rheumatology|August 30, 2017
Efficacy and tolerability of six-week extended dosing interval with tocilizumab therapy in a prospective cohort as remission maintenance in patients with rheumatoid arthritisJun Kikuchi, Tsuneo Kondo, Akiko Shibata, et al.
International Journal of Rheumatic Diseases|October 19, 2019
Tocilizumab monotherapy for polymyalgia rheumatica: A prospective, single-center, open-label studyKentaro Chino, Tsuneo Kondo, Ryota Sakai, et al.
Pageof 4